COPD

The Pharmacy Times® Chronic Obstructive Pulmonary Disease (COPD) resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

What can we help you find?

FDA Approves Budesonide/Glycopyrrolate/Formoterol Fumarate for Treatment of Patients With COPD

Budesonide/glycopyrrolate/formoterol fumarate (Breztri Aerosphere, AstraZeneca) has been approved by the FDA for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), according to a press release.

New Study Finds Lung Development Connection to COPD in Smokers Versus Non-Smokers

Although COPD often develops as a result of smoking, researchers have long puzzled over why nearly one-third of cases occur in people who never smoked.

Pharmacists’ Role in Tackling Social Determinants of Health

At the first educational session of PQA, the speakers discussed pharmacists’ roles in influencing outcomes associated with social determinants of health in the US population.

Study: COPD Linked to Risk of Lung Cancer in Non-Smokers

During this period, 1834 participants developed lung cancer, of whom 290 had COPD and 1544 did not, according to the researchers.

New Report Emphasizes Pharmacist’s Role in Smoking Cessation

Over $170 billion in health care spending is attributed to smoking.

Individualized COPD Therapy May Reduce Exacerbations, Costs

As COPD progresses, patients can experience exacerbations leading to a decreased quality of life and increased costs.

Shared Decision-Making and Patient Engagement Significantly Improve Long-Term COPD Outcomes

Chronic obstructive pulmonary disease (COPD) leads in hospital costs, physician services, and prescription drugs.

Investigators Propose Tool for Managing COPD and Use of Inhaled Corticosteroids

Investigators have proposed a tool involving a personalized approach for managing chronic obstructive pulmonary disease (COPD) and the use of inhaled corticosteroids (ICS), according to the results of a recent study published in the International Journal of Chronic Obstructive Pulmonary Disease.

Individualizing COPD Treatment to Improve Adherence and Overall Outcomes

Continuing education for pharmacists.

Class of Cancer Drugs May Have Potential as Chronic Obstructive Pulmonary Disease Treatment

The ErbB inhibitors, gefitinib, erbstatin, and tryphostin AG825, inhibit a cell signaling process controlling the death-rate of neutrophils, immune cells, which cause damage to the lungs.

High Levels of Ozone, Wood Burning Linked to Chronic Obstructive Pulmonary Disease Among Smokers, Nonsmokers

Two studies linked ozone levels and wood burning as a source of heat to an increased risk of developing chronic obstructive pulmonary disease.

Digital Health Tool Improves Health Outcomes for Patients with COPD

The tool, which works by attaching a small sensor to the patient’s inhaler, collects data on medication use and sends medication reminders, progress reports, and disease insights to the patient’s smartphone or hub.

The Pharmacy Times® COPD condition center provides a source of all the latest clinical information, with articles covering an array of progressive lung diseases, like emphysema, chronic bronchitis, and refractory asthma, as well as the robust pipeline of novel COPD therapies. It also serves as a hub of information and news from the upcoming and ongoing conferences and annual meetings of pulmonologists, including pivotal coverage right from the floor.

Among its other resources are a wealth of videos including interviews with thought leaders and experts in COPD, and moderated Peer Exchange panel discussions about the best practices and key methods for treating complex cases, utilizing the newest therapies, examining the issues and challenges of treating the disease, and much more.